Carson Advisory Inc. Viatris Inc Transaction History

Carson Advisory Inc.

$151 Million
Q3 2024

A detailed history of Carson Advisory Inc. transactions in Viatris Inc stock. As of the latest transaction made, Carson Advisory Inc. holds 54,750 shares of VTRS stock, worth $685,470. This represents 0.42% of its overall portfolio holdings.

Number of Shares

54,750

Previous 55,432 1.23%

Holding current value

$685,470

Previous $589,000 7.81%

% of portfolio

0.42%

Previous 0.43%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$10.32 - $12.13 $7,038 - $8,272	-682 Reduced 1.23%	54,750 $635,000
Q2 2024 Aug 07, 2024	BUY	$10.05 - $12.02 $1,316 - $1,574	131 Added 0.24%	55,432 $589,000
Q1 2024 May 03, 2024	BUY	$11.27 - $13.53 $63,112 - $75,768	5,600 Added 11.27%	55,301 $660,000
Q4 2023 Feb 06, 2024	SELL	$8.77 - $10.85 $20,197 - $24,987	-2,303 Reduced 4.43%	49,701 $538,000
Q3 2023 Nov 08, 2023	SELL	$9.59 - $11.35 $34,504 - $40,837	-3,598 Reduced 6.47%	52,004 $512,000
Q2 2023 Jul 28, 2023	BUY	$9.02 - $10.29 $501,530 - $572,144	55,602 New	55,602 $554,000
Q1 2023 May 05, 2023	SELL	$9.2 - $12.26 $36,846 - $49,101	-4,005 Reduced 6.14%	61,187 $588,000
Q4 2022 Feb 08, 2023	SELL	$8.72 - $11.56 $91,900 - $121,830	-10,539 Reduced 13.92%	65,192 $725,000
Q3 2022 Nov 07, 2022	SELL	$8.48 - $11.13 $18,596 - $24,408	-2,193 Reduced 2.81%	75,731 $645,000
Q2 2022 Aug 03, 2022	BUY	$9.95 - $12.27 $54,724 - $67,485	5,500 Added 7.59%	77,924 $816,000
Q1 2022 May 03, 2022	BUY	$9.81 - $15.4 $216,575 - $339,985	22,077 Added 43.85%	72,424 $788,000
Q4 2021 Feb 08, 2022	BUY	$12.09 - $14.68 $608,695 - $739,093	50,347 New	50,347 $681,000

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

933M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carson Advisory Inc., based on Form 13F filings with the SEC.

News

Stay updated on Carson Advisory Inc. with notifications on news.

Account

Carson Advisory Inc. Viatris Inc Transaction History